Thus, the net consequences of an increase in ACSL4 activity in the context of AKI must be assessed, taking into account both a dynamic aspect of the expression of the enzyme and the presence of partners necessary for the execution of a particular pathway. This evidence concerns the gene ACSL4 and acute kidney injury.